1.46
Polyrizon Ltd stock is traded at $1.46, with a volume of 3.48M.
It is up +0.69% in the last 24 hours and up +97.56% over the past month.
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.
See More
Previous Close:
$1.45
Open:
$1.46
24h Volume:
3.48M
Relative Volume:
0.54
Market Cap:
$7.78M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.69%
1M Performance:
+97.56%
6M Performance:
-99.55%
1Y Performance:
+0.00%
Polyrizon Ltd Stock (PLRZ) Company Profile
Compare PLRZ with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
PLRZ
Polyrizon Ltd
|
1.46 | 7.73M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
468.41 | 118.34B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
558.14 | 60.31B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
330.55 | 42.35B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
598.79 | 36.43B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
305.74 | 31.87B | 3.81B | -644.79M | -669.77M | -6.24 |
Polyrizon Ltd Stock (PLRZ) Latest News
Signal strength of Polyrizon Ltd. stock in tech scannersRisk Aware Trading Ideas with Alert Levels - Newser
What MACD and RSI say about Polyrizon Ltd.Free Strong Buy With Technical Confidence - Newser
Historical volatility pattern of Polyrizon Ltd. visualizedInvestment Timeline and ROI Summary Report - Newser
Advanced analytics toolkit walkthrough for Polyrizon Ltd.Buy Candidate Summary Based on Fundamentals - Newser
Detecting price anomalies in Polyrizon Ltd. with AIChart Driven Entry Timing for Swing Trades - Newser
Trend analysis for Polyrizon Ltd. this weekTrade Setup Builder with Custom Alerts - Newser
Identifying reversal signals in Polyrizon Ltd.AI Model Forecasting Reversal and Breakout Zones - Newser
Will Polyrizon Ltd. stock split in the near futureWatchlist Summary for Active Day Traders - Newser
Polyrizon Ltd. Stock Support and Resistance Levels You Should KnowShort-Term Upside Breakout Forecast System - Newser
Has Polyrizon Ltd. formed a bullish divergenceMarket Ready Picks with Technical Support - Newser
Technical signs of recovery in Polyrizon Ltd.Free Triple Digit Return Stock Predictions - Newser
Will Polyrizon Ltd. stock split in the near future Watchlist Generator for Smart Money Signals - Newser
Does Polyrizon Ltd. stock perform well during market downturnsFree Risk Assessment Services - jammulinksnews.com
What are the latest earnings results for Polyrizon Ltd.Get daily updates on promising stocks - jammulinksnews.com
What makes Polyrizon Ltd. stock price move sharplyMaximize returns with strategic trading plans - jammulinksnews.com
How many analysts rate Polyrizon Ltd. as a “Buy”Accelerated wealth expansion - jammulinksnews.com
Polyrizon Ltd. Company’s Quarterly Earnings Growth: What the Numbers SayFree Investing Community - Newser
What is Polyrizon Ltd. company’s growth strategyGet alerts on high-potential market moves - jammulinksnews.com
Biotech Alert: Searches spiking for these stocks today - TipRanks
How Polyrizon Ltd. stock reacts to Fed policy changesFree Market Volatility Navigation Tips - jammulinksnews.com
Is Polyrizon Ltd. a good long term investmentSky-high return potential - PrintWeekIndia
Why Did Polyrizon Plunge 11.7% Despite PL-14 Success? - AInvest
Polyrizon Ltd. Stock Analysis and ForecastExceptional growth trajectory - jammulinksnews.com
Polyrizon Stock Soars 37.93% on Nasal Allergy Breakthrough - AInvest
Why Did Polyrizon Stock Soar 26.21%? - AInvest
What drives Polyrizon Ltd. stock priceDynamic investment growth - jammulinksnews.com
What analysts say about Polyrizon Ltd. stockDynamic capital growth - jammulinksnews.com
Polyrizon stock soars after promising nasal allergy blocker test results By Investing.com - Investing.com South Africa
Polyrizon Skyrockets 66% Intraday—Can This Nasal Allergy Breakthrough Reshape Biotech? - AInvest
Polyrizon Skyrockets 61.93% Intraday, Is This the Dawn of a Biotech Breakthrough? - AInvest
Polyrizon stock soars after promising nasal allergy blocker test results - Investing.com India
Polyrizon Ltd. Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study - MarketScreener
Polyrizon Achieves Breakthrough in Allergy Blocker Study - TipRanks
Polyrizon’s nasal allergy blocker shows promising deposition results By Investing.com - Investing.com Nigeria
Polyrizon's Nasal Barrier: A Disruptive Leap in Allergy Therapeutics? - AInvest
Polyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study - The Manila Times
Breakthrough: New Allergy Blocker Shows 60% Success Rate in Nasal Delivery StudyMajor Step for $210M Market - Stock Titan
Polyrizon retains Nasdaq listing following hearings panel - MSN
Polyrizon Ltd Stock (PLRZ) Financials Data
There is no financial data for Polyrizon Ltd (PLRZ). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):